Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT02051218Phase 3Terminated
Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks
Bone MetastasesMetastatic Breast CancerMetastatic Prostate Cancer
StudychairStart date: 2014-07-16
NCT00976755Phase 2Completed
Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer
Prostate Cancer
PrincipalinvestigatorStart date: 2009-09-14

Research Network

Collaboration Network

8 collaborators·11 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Cantonal Hospital of St. Gallen

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Silke Gillessen, Prof

Cantonal Hospital of St. Gallen

Moderately Similar
4 trials

Shared therapeutic areas:

Prostate CancerBone MetastasesMetastatic Breast Cancer+1 more

Worked with same sponsors:

Swiss Cancer Institute
Collaborated on 1 trial
Similarity Score44%

Roger von Moos, PD MD

Kantonsspital GraubĂ¼nden

Moderately Similar
1 trials

Shared therapeutic areas:

Bone MetastasesMetastatic Breast CancerMetastatic Prostate Cancer

Worked with same sponsors:

Swiss Cancer Institute
Collaborated on 1 trial
Similarity Score34%

Andreas MĂ¼ller, MD

Kantonsspital Winterthur KSW

Moderately Similar
1 trials

Shared therapeutic areas:

Bone MetastasesMetastatic Breast CancerMetastatic Prostate Cancer

Worked with same sponsors:

Swiss Cancer Institute
Collaborated on 1 trial
Similarity Score34%

Stanislaw R. Burzynski, MD, PhD

Burzynski Research Institute

Related
62 trials

Shared therapeutic areas:

Metastatic Prostate CancerProstate Cancer
Similarity Score15%

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Prostate CancerMetastatic Prostate Cancer
Similarity Score15%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Metastatic Breast CancerMetastatic Prostate Cancer
Similarity Score15%

Silke Gillessen, MD

Cantonal Hospital of St. Gallen

Related
3 trials

Shared therapeutic areas:

Prostate Cancer

Worked with same sponsors:

Swiss Cancer Institute
Collaborated on 1 trial
Similarity Score14%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Metastatic Breast Cancer
Similarity Score8%

Kevin Volpp, MD, PhD

University of Pennsylvania

Related
12 trials

Shared therapeutic areas:

Prostate Cancer
Similarity Score8%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Prostate Cancer
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02051218Phase 3StudyChair

Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks

Bone MetastasesMetastatic Breast CancerMetastatic Prostate Cancer
Terminated
NCT00976755Phase 2PrincipalInvestigator

Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer

Prostate Cancer
Completed

All 2 trials loaded